Have You Ever Wonder if the US Government Have Kept Sercets From the Rest of the World?

Question by Asking a question: Have you ever wonder if the US Government have kept sercets from the rest of the world?
Well, l’m just wondering if they are keeping secrets and is so, l would love to know what they are secrets they are keeping from us and why.

Best answer:

Answer by bittermeds
Bush’s presidency is all about secrets.

What do you think? Answer below!

 


 

INSynergy Provides VIVITROL for heroin and opiate pain pill Addiction | Call (314) 649-7867 (STOP) – Call 314-649-STOP (7867) INSynergy is the Premier Alcohol and Drug Rehab Treatment Center in St. Louis, MO. INSynergy Provides VIVITROL for heroin and opiate pain pill addiction. – Detox from heroin and alcohol as an outpatient – Alternative to AA and 12 Step Programs – Highly Confidential – Modern Day Approach to Addiction Treatment – Medically Assisted Detox – Minimal Disruption from professional, academic, personal, life – MD is Board Certified in Addiction Medicine – created at animoto.com

 

International consortium builds 'Google Map' of human metabolism

Filed under: drug treatment programs maryland

Recon 2 allows researchers to use this existing gene expression data and knowledge of the entire metabolic network to figure how certain drugs would affect specific metabolic pathways found to create the conditions for cancerous cell growth, for …
Read more on Eureka! Science News

 

Shape Pharmaceuticals Provides Update on SHP-141 Topical HDAC Inhibitor

Filed under: drug treatment programs maryland

Shape Pharmaceuticals today provided an update on the clinical development of SHP-141, its novel, topically administered histone deacetylase inhibitor (HDACi) for the treatment of cutaneous T cell lymphoma (CTCL). … Michael Krathen, MD, Clinical …
Read more on Fort Mills Times

 

Intercept Pharmaceuticals Appoints Daniel Regan as Chief Commercial Officer

Filed under: drug treatment programs maryland

OCA is initially being developed for the second line treatment of primary biliary cirrhosis (PBC) in patients with an inadequate response to, or who are unable to tolerate, ursodiol, the only approved therapy for this indication. OCA has received …
Read more on NASDAQ